Clinical Trial Update: Toripalimab Plus TPF Chemotherapy and Radiotherapy for LA-HPSCC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating toripalimab in combination with TPF chemotherapy and radiotherapy for locally advanced hypopharyngeal squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopharyngeal Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yan | Conditions: Hypopharyngeal Neoplasm Malignant Primary | Phase 2 | Status: UNKNOWN